FRANK DANIEL 4
4 · Molecular Insight Pharmaceuticals, Inc. · Filed May 17, 2010
Insider Transaction Report
Form 4
FRANK DANIEL
Director
Transactions
- Award
Stock Option (right to buy)
2010-05-13−25,000→ 25,000 totalExercise: $1.85From: 2011-05-13→ Common Stock (25,000 underlying)
Footnotes (2)
- [F1]This option is an automatic annual grant.
- [F2]This option terminates on the earlier of (i) ninety (90) days after the reporting person ceases to be a director of the Issuer or (ii) May 13, 2020.